Andrew J Morris Selected Research

Fatty Liver

1/2019	Proteomic Analysis Reveals Novel Mechanisms by Which Polychlorinated Biphenyls Compromise the Liver Promoting Diet-Induced Steatohepatitis.
12/2017	Editor's Highlight: PCB126 Exposure Increases Risk for Peripheral Vascular Diseases in a Liver Injury Mouse Model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew J Morris Research Topics

Disease

23	Inflammation (Inflammations) 12/2021 - 10/2005
20	Neoplasms (Cancer) 01/2022 - 03/2003
14	Atherosclerosis 12/2020 - 04/2009
13	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 08/2008
12	Obesity 01/2022 - 08/2011
7	Insulin Resistance 01/2021 - 04/2012
7	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 03/2014
5	Neoplasm Metastasis (Metastasis) 01/2019 - 03/2009
5	Vascular System Injuries 01/2019 - 08/2008
5	Ovarian Neoplasms (Ovarian Cancer) 06/2012 - 03/2003
4	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 03/2012
4	Weight Loss (Weight Reduction) 08/2019 - 01/2013
4	Body Weight (Weight, Body) 08/2019 - 11/2015
3	Sepsis (Septicemia) 01/2021 - 01/2013
3	Mental Disorders (Mental Disorder) 11/2020 - 01/2016
3	Fibrosis (Cirrhosis) 01/2019 - 04/2016
3	Thrombosis (Thrombus) 01/2012 - 08/2008
2	Hyperlipidemias (Hyperlipidemia) 12/2021 - 11/2019
2	Thrombocytopenia (Thrombopenia) 01/2021 - 01/2013
2	Hemorrhage 01/2021 - 03/2009
2	Glucose Intolerance 06/2020 - 01/2019
2	Wounds and Injuries (Trauma) 01/2020 - 08/2013
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2019 - 09/2013
2	Metabolic Diseases (Metabolic Disease) 12/2019 - 03/2017
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2019 - 01/2017
2	Mitochondrial Diseases (Mitochondrial Disease) 02/2019 - 01/2018
2	Fatty Liver 01/2019 - 12/2017
2	Colonic Neoplasms (Colon Cancer) 09/2017 - 01/2011
2	Cardiotoxicity 11/2015 - 11/2015
2	Myocardial Infarction 10/2015 - 06/2013
2	Asthma (Bronchial Asthma) 04/2015 - 10/2013
2	Atherosclerotic Plaque (Atheroma) 04/2015 - 10/2003
2	Breast Neoplasms (Breast Cancer) 02/2014 - 09/2013
2	Hyperplasia 01/2013 - 04/2009
2	Type 2 Diabetes Mellitus (MODY) 01/2013 - 04/2012
2	Ascites 09/2003 - 03/2003
1	Aneurysm (Aneurysms) 01/2022
1	Rupture 01/2022

Drug/Important Bio-Agent (IBA)

23	LipidsIBA 01/2021 - 03/2003
20	lysophosphatidic acidIBA 01/2022 - 03/2003
10	EnzymesIBA 01/2020 - 03/2003
9	Lysophosphatidic Acid ReceptorsIBA 01/2022 - 08/2008
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2003
7	Polychlorinated Biphenyls (PCBs)IBA 01/2022 - 02/2011
7	lipid phosphate phosphataseIBA 01/2022 - 09/2003
6	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2013
6	3,4,5,3',4'-pentachlorobiphenylIBA 12/2020 - 12/2017
6	Phosphates (Orthophosphate)IBA 12/2020 - 03/2003
6	Biological ProductsIBA 01/2020 - 08/2008
6	Phosphotransferases (Kinase)IBA 12/2019 - 04/2010
6	Fatty Acids (Saturated Fatty Acids)IBA 01/2019 - 06/2012
6	SphingolipidsIBA 01/2019 - 04/2012
5	LysophospholipidsIBA 01/2022 - 01/2012
5	CeramidesIBA 12/2021 - 03/2003
5	Biomarkers (Surrogate Marker)IBA 12/2020 - 01/2012
5	Phospholipids (Phosphatides)FDA LinkGeneric 11/2020 - 03/2014
4	LDL Receptors (LDL Receptor)IBA 01/2020 - 01/2018
4	trimethyloxamine (trimethylamine N-oxide)IBA 12/2019 - 01/2016
4	Environmental Pollutants (Pollutants, Environmental)IBA 01/2019 - 02/2016
4	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2019 - 01/2012
4	LigandsIBA 01/2019 - 06/2010
4	SphingosineIBA 01/2019 - 03/2003
3	NexusIBA 12/2020 - 03/2014
3	DioxinsIBA 06/2020 - 01/2018
3	Transcription Factors (Transcription Factor)IBA 12/2019 - 01/2019
3	oxidized low density lipoproteinIBA 11/2019 - 04/2010
3	CytokinesIBA 08/2019 - 01/2013
3	3,4,3',4'-tetrachlorobiphenylIBA 01/2019 - 01/2013
3	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2019 - 10/2015
3	Messenger RNA (mRNA)IBA 01/2019 - 09/2003
3	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2019 - 03/2012
3	Insulin (Novolin)FDA Link 10/2018 - 05/2013
3	IntegrinsIBA 02/2014 - 03/2009
3	Phospholipase DIBA 02/2011 - 10/2003
2	Complement System Proteins (Complement)IBA 01/2022 - 01/2019
2	Persistent Organic PollutantsIBA 01/2022 - 01/2018
2	mirabegronIBA 01/2021 - 01/2020
2	Inulin FDA Link 06/2020 - 01/2020
2	CholesterolIBA 05/2020 - 01/2019
2	AntibodiesIBA 01/2020 - 02/2014
2	Choline (Choline Chloride)IBA 01/2020 - 02/2019
2	1-dodecylpyridoxal (PLD)IBA 01/2020 - 03/2009
2	TVB-3664IBA 01/2019 - 05/2018
2	Membrane Proteins (Integral Membrane Proteins)IBA 11/2017 - 03/2003
2	Pharmaceutical PreparationsIBA 09/2017 - 04/2010
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2015 - 11/2015
2	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2015 - 10/2005
2	AdiponectinIBA 05/2015 - 05/2013
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 05/2013 - 02/2011
2	Interleukin-6 (Interleukin 6)IBA 01/2013 - 01/2012
2	LipopolysaccharidesIBA 01/2013 - 01/2012
2	RNA Splicing FactorsIBA 03/2012 - 08/2011
2	alkylglycerophosphoethanolamine phosphodiesteraseIBA 01/2012 - 03/2009
2	Phosphatidic Acids (Phosphatidic Acid)IBA 02/2011 - 03/2003
1	NF-kappa B (NF-kB)IBA 01/2022
1	Angiotensin IIIBA 01/2022
1	FluorocarbonsIBA 01/2022

Therapy/Procedure

6	Therapeutics 01/2021 - 03/2003
3	Drug Therapy (Chemotherapy) 01/2018 - 03/2003
2	Platelet Transfusion (Blood Platelet Transfusions) 01/2021 - 01/2013